Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
Take Tell Us What YOU Think! Take The Body's Visitor Survey!
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News Briefs

World Health Organization Hails Pharmacia's Generic HIV/AIDS Treatment Accord

From U.S. Centers for Disease Control and Prevention

January 28, 2003

On Monday in Geneva, the World Health Organization hailed the news that Pharmacia will license a Dutch group to provide developing countries with a generic treatment for HIV/AIDS. The U.S. drug maker on Friday confirmed a partnership with the Dutch foundation International Dispensary Association to grant non-exclusive licenses for the HIV/AIDS drug delavirdine to generic pharmaceutical companies. "WHO welcomes new initiatives by some innovator companies to license their patents for certain HIV/AIDS medicines to generic companies," the UN agency said in a statement. "Such voluntary licensing can increase competition, reduce prices, and thereby give poorer people greater access to medicines."

Back to other CDC news for January 28, 2003

Previous Updates

Adapted from:
Agence France Presse
01.27.03

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
 

Advertisement